Much of the progress of the past 5 decades was catalyzed by the National Cancer Act, signed into law by President Richard Nixon in December 1971.
Our oncology training is shaped by those who devote their time to helping us turn our weaknesses into strengths, and all of us have a role to play as teachers.
In their roles as patient advocates, Ms. Janine Guglielmino and Dr. Sue Friedman have observed growing patient confusion about breast cancer subtypes and the difference between acquired and inherited gene mutations.
"Leading right now means helping team members adapt to the losses that all have experienced and supporting them with more than exhortation and reassurance," writes Dr. Mark E. Robson.
Meeyoung Lee and I discuss expectations, goals, realism, and hope when recommending a phase I clinical trial to a patient with cancer.